Net Loss of Unichem Laboratories reported to Rs 129.31 crore in the quarter ended March 2024 as against net loss of Rs 44.27 crore during the previous quarter ended March 2023. Sales rose 7.36% to Rs 431.70 crore in the quarter ended March 2024 as against Rs 402.10 crore during the previous quarter ended March 2023.For the full year,net loss reported to Rs 70.47 crore in the year ended March 2024 as against net loss of Rs 202.23 crore during the previous year ended March 2023. Sales rose 26.94% to Rs 1704.89 crore in the year ended March 2024 as against Rs 1343.02 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales431.70402.10 7 1704.891343.02 27 OPM %5.874.10 -5.88-3.39 - PBDT26.9116.07 67 109.18-24.35 LP PBT-0.25-13.62 98 -4.06-137.79 97 NP-129.31-44.27 -192 -70.47-202.23 65 Powered by Capital Market - Live News

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 22 May 2024Powered by Capital Market - Live News

Net profit of Unichem Laboratories reported to Rs 83.99 crore in the quarter ended December 2023 as against net loss of Rs 63.93 crore during the previous quarter ended December 2022. Sales rose 43.60% to Rs 434.38 crore in the quarter ended December 2023 as against Rs 302.50 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales434.38302.50 44 OPM %8.78-14.14 - PBDT43.82-30.50 LP PBT15.96-61.28 LP NP83.99-63.93 LP Powered by Capital Market - Live News

Unichem Laboratories will hold a meeting of the Board of Directors of the Company on 5 February 2024.Powered by Capital Market - Live News

Unichem Laboratories has received ANDA approval for its Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Cardura� (Doxazosin) Tablets, 1 mg, 2 mg, 4 mg and 8 mg, of Viatris Specialty, LLC.Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure. The product will be commercialized from Unichem`s Goa Plant. Powered by Capital Market - Live News